GlassScriptPhysician profile
Adam Badaczewski
NPI 1255726071
$959.92
in general payments reported to CMS, 2019-2025
9 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.48 · 2020: $12.84 · 2024: $793 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $632 · Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $632.15 |
| Food and Beverage | $262.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Piedmont Plus Innovation | $510.56 | 2024 | |
| Arthrex, INC. | $282.65 | 2024 | |
| Acera Surgical, INC. | $65.60 | 2025 | Restrata Wound Matrix |
| Horizon Therapeutics Plc | $23.04 | 2019 | |
| Smith+Nephew, INC. | $18.63 | 2025 | Collagenase Santyl |
| Tactile Systems Technology INC | $17.82 | 2019 | |
| Lifenet Health | $17.16 | 2025 | Theragenesis Wound Matrix |
| Stryker Corporation | $12.84 | 2020 | |
| Pfizer INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Badaczewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.